AZN vs. ABX.TO
AZN (AstraZeneca PLC) and ABX.TO (Barrick Gold Corporation) are both stocks. AZN operates in Drug Manufacturers - General (Healthcare), while ABX.TO operates in Gold (Basic Materials). Over the past 10 years, AZN returned 15.97%/yr vs 9.36%/yr for ABX.TO. At a 0.13 correlation, their price movements are largely independent.
Performance
AZN vs. ABX.TO - Performance Comparison
Loading charts...
Different Trading Currencies
AZN is traded in USD, while ABX.TO is traded in CAD. To make them comparable, the ABX.TO values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, AZN achieves a 1.85% return, which is significantly higher than ABX.TO's -9.32% return. Over the past 10 years, AZN has outperformed ABX.TO with an annualized return of 15.97%, while ABX.TO has yielded a comparatively lower 9.36% annualized return.
AZN
- 1D
- 1.04%
- 1M
- 0.32%
- YTD
- 1.85%
- 6M
- 4.25%
- 1Y
- 29.14%
- 3Y*
- 9.91%
- 5Y*
- 11.83%
- 10Y*
- 15.97%
ABX.TO
- 1D
- -0.99%
- 1M
- -9.18%
- YTD
- -9.32%
- 6M
- -3.25%
- 1Y
- 96.99%
- 3Y*
- 35.14%
- 5Y*
- 13.99%
- 10Y*
- 9.36%
AZN vs. ABX.TO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AZN AstraZeneca PLC | 1.85% | 43.30% | -0.62% | 1.44% | 19.14% | 19.66% | 3.12% | 35.68% | 13.86% | 33.10% |
ABX.TO Barrick Gold Corporation | -9.38% | 187.00% | -12.13% | 8.23% | -4.75% | -13.94% | 24.68% | 37.48% | -5.29% | -8.71% |
Correlation
The correlation between AZN and ABX.TO is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.18 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.20 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Jul 7, 2006 | 0.13 |
Fundamentals
AZN:
$286.33B
ABX.TO:
CA$91.34B
AZN:
$6.66
ABX.TO:
CA$3.60
AZN:
27.56
ABX.TO:
15.16
AZN:
0.04
ABX.TO:
0.17
AZN:
4.74
ABX.TO:
4.86
AZN:
6.05
ABX.TO:
3.34
AZN:
$60.44B
ABX.TO:
CA$19.02B
AZN:
$49.37B
ABX.TO:
CA$10.15B
AZN:
$20.47B
ABX.TO:
CA$12.44B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AZN vs. ABX.TO — Risk / Return Rank
AZN
ABX.TO
AZN vs. ABX.TO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AstraZeneca PLC (AZN) and Barrick Gold Corporation (ABX.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| AZN | ABX.TO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.03 | ||
| Sortino ratioReturn per unit of downside risk | -0.64 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.35 | -0.14 |
| Calmar ratioReturn relative to maximum drawdown | 1.91 | 3.34 | -1.43 |
| Martin ratioReturn relative to average drawdown | 5.05 | 8.31 | -3.27 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| AZN | ABX.TO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.15 | 2.18 | -1.03 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.50 | 0.40 | +0.10 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.64 | 0.26 | +0.39 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.50 | 0.07 | +0.43 |
Drawdowns
AZN vs. ABX.TO - Drawdown Comparison
The maximum AZN drawdown since its inception was -48.94%, smaller than the maximum ABX.TO drawdown of -88.57%. Use the drawdown chart below to compare losses from any high point for AZN and ABX.TO.
Loading charts...
Drawdown Indicators
| AZN | ABX.TO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -48.94% | -88.57% | +39.63% |
Max Drawdown (1Y)Largest decline over 1 year | -15.43% | -29.24% | +13.81% |
Max Drawdown (3Y)Largest decline over 3 years | -27.87% | -29.24% | +1.37% |
Max Drawdown (5Y)Largest decline over 5 years | -27.87% | -46.90% | +19.03% |
Max Drawdown (10Y)Largest decline over 10 years | -27.87% | -57.25% | +29.38% |
Current DrawdownCurrent decline from peak | -12.00% | -25.12% | +13.12% |
Average DrawdownAverage peak-to-trough decline | -11.37% | -48.13% | +36.76% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.80% | 11.71% | -5.91% |
Volatility
AZN vs. ABX.TO - Volatility Comparison
The current volatility for AstraZeneca PLC (AZN) is 7.49%, while Barrick Gold Corporation (ABX.TO) has a volatility of 16.61%. This indicates that AZN experiences smaller price fluctuations and is considered to be less risky than ABX.TO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AZN | ABX.TO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.49% | 16.61% | -9.12% |
Volatility (6M)Calculated over the trailing 6-month period | 17.47% | 34.09% | -16.62% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.51% | 44.69% | -19.18% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.00% | 35.29% | -11.29% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.91% | 36.47% | -11.56% |
Dividends
AZN vs. ABX.TO - Dividend Comparison
AZN's dividend yield for the trailing twelve months is around 2.90%, more than ABX.TO's 2.32% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABX.TO Barrick Gold Corporation | 2.32% | 1.22% | 2.46% | 2.27% | 4.77% | 3.96% | 1.33% | 0.60% | 1.17% | 0.72% | 0.47% | 1.43% |
AZN AstraZeneca PLC | 2.90% | 1.70% | 2.27% | 2.15% | 2.12% | 2.35% | 2.80% | 2.81% | 3.69% | 3.95% | 5.01% | 4.06% |
Financials
AZN vs. ABX.TO - Financials Comparison
This section allows you to compare key financial metrics between AstraZeneca PLC and Barrick Gold Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AZN vs. ABX.TO - Profitability Comparison
AZN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported a gross profit of 12.61B and revenue of 15.29B. Therefore, the gross margin over that period was 82.5%.
ABX.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Barrick Gold Corporation reported a gross profit of 2.97B and revenue of 5.16B. Therefore, the gross margin over that period was 57.5%.
AZN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported an operating income of 4.25B and revenue of 15.29B, resulting in an operating margin of 27.8%.
ABX.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Barrick Gold Corporation reported an operating income of 2.93B and revenue of 5.16B, resulting in an operating margin of 56.7%.
AZN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported a net income of 3.08B and revenue of 15.29B, resulting in a net margin of 20.2%.
ABX.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Barrick Gold Corporation reported a net income of 1.58B and revenue of 5.16B, resulting in a net margin of 30.5%.
Frequently Asked Questions
AZN and ABX.TO have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for AZN and ABX.TO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer